GLEN HJ STEVENS

Summary

Affiliation: Cleveland Clinic Foundation
Country: USA

Publications

  1. ncbi Antiepileptic therapy in patients with central nervous system malignancies
    Glen H J Stevens
    Brain Tumor Institute, Taussig Cancer Center R20, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Curr Neurol Neurosci Rep 6:311-8. 2006
  2. ncbi Validation of the RTOG recursive partitioning analysis (RPA) classification for small-cell lung cancer-only brain metastases
    Gregory M M Videtic
    Department of Radiation Oncology, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Int J Radiat Oncol Biol Phys 67:240-3. 2007
  3. ncbi Intensity-modulated radiation therapy (IMRT) for newly diagnosed and recurrent intracranial meningiomas: preliminary results
    Ratna Sajja
    Department of Radiation Oncology, Brain Tumor Institute, Cleveland Clinic Foundation, OH 44195, USA
    Technol Cancer Res Treat 4:675-82. 2005
  4. ncbi Brain-invasive solitary fibrous tumor of the meninges: report of a case
    Elias A Castilla
    Department of Anatomic Pathology, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Int J Surg Pathol 10:217-21. 2002
  5. ncbi Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue arising in the lateral ventricle
    Todd W Kelley
    Division of Pathology and Laboratory Medicine, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44195, USA
    Leuk Lymphoma 46:1423-7. 2005
  6. ncbi Epidermal growth factor receptor amplification does not have prognostic significance in patients with glioblastoma multiforme
    Aimee L Quan
    Department of Radiation Oncology, Brain Tumor Institute, The Cleveland Clinic Taussig Cancer Center, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Int J Radiat Oncol Biol Phys 63:695-703. 2005
  7. ncbi New frontiers in translational research in neuro-oncology and the blood-brain barrier: report of the tenth annual Blood-Brain Barrier Disruption Consortium Meeting
    Nancy D Doolittle
    Department of Neurology, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97201, USA
    Clin Cancer Res 11:421-8. 2005
  8. ncbi Results of whole brain radiotherapy and recursive partitioning analysis in patients with brain metastases from renal cell carcinoma: a retrospective study
    Steven B Cannady
    Department of Otolaryngology, Brain Tumor Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Int J Radiat Oncol Biol Phys 58:253-8. 2004
  9. ncbi Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions
    Andrew A Kanner
    Brain Tumor Institute, The Cleveland Clinic, Ohio 44195, USA
    Cancer 97:2806-13. 2003
  10. ncbi Gliomatosis cerebri: treatment results with radiotherapy alone
    Mohamed A Elshaikh
    Department of Radiation Oncology, Brain Tumor Institute, Cleveland Clinic Foundation, Ohio 44195, USA
    Cancer 95:2027-31. 2002

Research Grants

  1. 5-Lipoxygenase inhibition as an adjuvant glioma therapy
    Glen Stevens; Fiscal Year: 2005

Collaborators

Detail Information

Publications11

  1. ncbi Antiepileptic therapy in patients with central nervous system malignancies
    Glen H J Stevens
    Brain Tumor Institute, Taussig Cancer Center R20, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Curr Neurol Neurosci Rep 6:311-8. 2006
    ..This review mainly includes primary brain tumors, but most of the concepts are transferable to patients with metastatic tumors...
  2. ncbi Validation of the RTOG recursive partitioning analysis (RPA) classification for small-cell lung cancer-only brain metastases
    Gregory M M Videtic
    Department of Radiation Oncology, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Int J Radiat Oncol Biol Phys 67:240-3. 2007
    ..Clinical trials for patients with brain metastases generally exclude small-cell lung cancer (SCLC) cases. We hypothesize that the RPA classes are valid in the setting of SCLC brain metastases...
  3. ncbi Intensity-modulated radiation therapy (IMRT) for newly diagnosed and recurrent intracranial meningiomas: preliminary results
    Ratna Sajja
    Department of Radiation Oncology, Brain Tumor Institute, Cleveland Clinic Foundation, OH 44195, USA
    Technol Cancer Res Treat 4:675-82. 2005
    ..A greater number of patients with longer follow-up after treatment may be needed to determine treatment variables predicting for long-term tumor control...
  4. ncbi Brain-invasive solitary fibrous tumor of the meninges: report of a case
    Elias A Castilla
    Department of Anatomic Pathology, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Int J Surg Pathol 10:217-21. 2002
    ..Focal infiltration into the underlying brain parenchyma was observed. The tumor was CD34 positive and EMA negative...
  5. ncbi Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue arising in the lateral ventricle
    Todd W Kelley
    Division of Pathology and Laboratory Medicine, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio 44195, USA
    Leuk Lymphoma 46:1423-7. 2005
    ..This rare case provides insight into the pathophysiology of MALT lymphomas...
  6. ncbi Epidermal growth factor receptor amplification does not have prognostic significance in patients with glioblastoma multiforme
    Aimee L Quan
    Department of Radiation Oncology, Brain Tumor Institute, The Cleveland Clinic Taussig Cancer Center, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Int J Radiat Oncol Biol Phys 63:695-703. 2005
    ..Further studies are needed to fully delineate the significance of this molecular marker in patients with GBM...
  7. ncbi New frontiers in translational research in neuro-oncology and the blood-brain barrier: report of the tenth annual Blood-Brain Barrier Disruption Consortium Meeting
    Nancy D Doolittle
    Department of Neurology, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97201, USA
    Clin Cancer Res 11:421-8. 2005
    ..Transport across the BBB relates to the neurovascular unit, which consists not only of endothelial cells but also of pericyte, glia, and neuronal elements...
  8. ncbi Results of whole brain radiotherapy and recursive partitioning analysis in patients with brain metastases from renal cell carcinoma: a retrospective study
    Steven B Cannady
    Department of Otolaryngology, Brain Tumor Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Int J Radiat Oncol Biol Phys 58:253-8. 2004
    ..The RTOG RPA classification system may be a useful tool in assessing prognosis in this patient population...
  9. ncbi Serum S100beta: a noninvasive marker of blood-brain barrier function and brain lesions
    Andrew A Kanner
    Brain Tumor Institute, The Cleveland Clinic, Ohio 44195, USA
    Cancer 97:2806-13. 2003
    ..Larger prospective studies may better determine the true specificity of S100beta as a marker for BBB function and as an early detection or follow-up marker of brain tumors...
  10. ncbi Gliomatosis cerebri: treatment results with radiotherapy alone
    Mohamed A Elshaikh
    Department of Radiation Oncology, Brain Tumor Institute, Cleveland Clinic Foundation, Ohio 44195, USA
    Cancer 95:2027-31. 2002
    ..Although brain radiotherapy controlled or stabilized disease progression in most patients, the overall survival after brain radiotherapy alone was not satisfactory. More aggressive therapy may be needed...
  11. ncbi Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma
    Anat Galor
    Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Am J Ophthalmol 144:45-49. 2007
    ..To report on the development of visually significant maculopathy associated with blood-brain barrier disruption (BBBD) therapy for the treatment of central nervous system (CNS) lymphoma...

Research Grants1

  1. 5-Lipoxygenase inhibition as an adjuvant glioma therapy
    Glen Stevens; Fiscal Year: 2005
    ..It would allow patients to "take charge" of their lives, which is itself a life enhancing experience and a major reason whv patients with GBM frequentlv use CAM therapies. ..